Ronan T Swords

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 2

Top Topics

Allogeneic Hematopoietic Stem Cell Transplantation

Prognostic Factors

Acute Lymphoblastic Leukemia

Top Venues

Blood cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Christopher A Eide, Stephen E Kurtz, Andy Kaempf, Nicola Long, Sunil Kumar Joshi, Tamilla Nechiporuk, Ariane Huang, Charles A Dibb, Akosha Taylor, Daniel Bottomly, Shannon K McWeeney, Jessica Minnier, Curtis A Lachowiez, Jennifer N Saultz, Ronan T Swords, Anupriya Agarwal, Bill H Chang, Brian J Druker, Jeffrey W Tyner
Clinical Correlates of Venetoclax-based Combination Sensitivities to Augment Acute Myeloid Leukemia Therapy. Blood cancer discovery (2023)
Ronan T Swords, Steven Coutre, Michael B Maris, Joshua F Zeidner, James M Foran, Jose Cruz, Harry P Erba, Jesus G Berdeja, Wayne Tam, Saran Vardhanabhuti, Lwona Dobler, Hélène M Faessel, Ajeeta B Dash, Farhad Sedarati, Douglas V Faller, Michael R Savona
Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, combined with azacitidine in patients with AML. Blood 131 (13) (2018)